In order to ensure the effective conduct of the inquiry stage of alleged infringements, the Agency and the Commission should have recourse to the competent authorities of the Member States, designated as the supervisory authorities of medicinal products authorised through the centralised procedure by Regulation (EC) No 726/2004, to carry out the necessary measures of inquiry and to obtain information relating to infringements falling within the scope of this Regulation. To that end, it is appropriate that the supervisory authorities conduct the inspection and surveillance activities for which they are competent in accordance with the provisions of Regulation (EC) No 726/2004, Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products [OJ L 311, 28.11.2001, p. 1. Directive as amended by Directive 2004/28/EC (OJ L 136, 30.4.2004, p. 58).] and Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [OJ L 311, 28.11.2001, p. 67. Directive as last amended by Regulation (EC) No 1901/2006.] and their implementing provisions.
Recital 6, Commission Regulation (EC) No 658/2007 of 14 June 2007 concerning financial penalties fo…
In forcesince 14 Jun 2007
Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…Law
- celex=32001L0082
- celex=32004L0028
- celex=32006L1901
- num:eu=2001/82